Athenex to present at the 39th annual j.p. morgan healthcare conference

Buffalo, n.y., jan. 05, 2021 (globe newswire) -- athenex, inc., (nasdaq: atnx), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, announced that it will participate in the 39th annual j. p. morgan healthcare conference. johnson lau, ceo and board chairman, and daniel lang, senior director, corporate development, will present a corporate overview at the conference.
ATNX Ratings Summary
ATNX Quant Ranking